Hans-Georg Klingemann

2.0k total citations
42 papers, 1.5k citations indexed

About

Hans-Georg Klingemann is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Hans-Georg Klingemann has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 16 papers in Immunology and 15 papers in Oncology. Recurrent topics in Hans-Georg Klingemann's work include Hematopoietic Stem Cell Transplantation (13 papers), Immune Cell Function and Interaction (11 papers) and CAR-T cell therapy research (8 papers). Hans-Georg Klingemann is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Immune Cell Function and Interaction (11 papers) and CAR-T cell therapy research (8 papers). Hans-Georg Klingemann collaborates with scholars based in Canada, United States and Germany. Hans-Georg Klingemann's co-authors include Donna Reece, M. J. Barnett, Torsten Tonn, Guitta Maki, Winfried S. Wels, Christoph Uherek, John D. Shepherd, Jeff Martinson, Elaine K. Wong and GL Phillips and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Hans-Georg Klingemann

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans-Georg Klingemann Canada 18 795 708 532 265 133 42 1.5k
W. Christopher Ehmann United States 18 762 1.0× 600 0.8× 433 0.8× 318 1.2× 238 1.8× 43 1.4k
Rosanna Scimè Italy 18 403 0.5× 363 0.5× 747 1.4× 271 1.0× 212 1.6× 51 1.2k
N. Schwella Germany 19 637 0.8× 262 0.4× 588 1.1× 85 0.3× 128 1.0× 54 1.4k
Alberto M. Marmont Italy 23 310 0.4× 525 0.7× 1.0k 1.9× 319 1.2× 345 2.6× 66 1.7k
Ginna G. Laport United States 27 870 1.1× 996 1.4× 1.2k 2.2× 483 1.8× 255 1.9× 94 2.1k
Maurizio Musso Italy 19 364 0.5× 277 0.4× 702 1.3× 334 1.3× 243 1.8× 68 1.4k
YL Kwong China 20 722 0.9× 355 0.5× 337 0.6× 520 2.0× 148 1.1× 56 1.2k
B. Glaß Germany 21 611 0.8× 403 0.6× 345 0.6× 624 2.4× 280 2.1× 55 1.2k
Alessandra Sperotto Italy 22 378 0.5× 418 0.6× 966 1.8× 293 1.1× 343 2.6× 55 1.5k
A Marmont Italy 16 457 0.6× 901 1.3× 1.5k 2.7× 320 1.2× 331 2.5× 43 2.1k

Countries citing papers authored by Hans-Georg Klingemann

Since Specialization
Citations

This map shows the geographic impact of Hans-Georg Klingemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Georg Klingemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Georg Klingemann more than expected).

Fields of papers citing papers by Hans-Georg Klingemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans-Georg Klingemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Georg Klingemann. The network helps show where Hans-Georg Klingemann may publish in the future.

Co-authorship network of co-authors of Hans-Georg Klingemann

This figure shows the co-authorship network connecting the top 25 collaborators of Hans-Georg Klingemann. A scholar is included among the top collaborators of Hans-Georg Klingemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans-Georg Klingemann. Hans-Georg Klingemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klingemann, Hans-Georg, et al.. (2008). Follikuläre lymphatische Hyperplasie des Dünndarmes bei Antikörpermangelsyndrom. DMW - Deutsche Medizinische Wochenschrift. 106(24). 775–778.
2.
Klingemann, Hans-Georg & Laurent Boissel. (2008). Targeted Cellular Therapy with Natural Killer Cells. Hormone and Metabolic Research. 40(2). 122–125. 9 indexed citations
3.
Müller, Tina, Christoph Uherek, Guitta Maki, et al.. (2007). Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells. Cancer Immunology Immunotherapy. 57(3). 411–423. 180 indexed citations
4.
Klingemann, Hans-Georg & Jeff Martinson. (2004). Ex vivo expansion of natural killer cells for clinical applications. Cytotherapy. 6(1). 15–22. 90 indexed citations
5.
Berkahn, Leanne, David Simpson, Anastasios Raptis, & Hans-Georg Klingemann. (2002). In Vivo Purging with Rituximab Prior to Collection of Stem Cells for Autologous Transplantation in Chronic Lymphocytic Leukemia. Journal of Hematotherapy & Stem Cell Research. 11(2). 315–320. 9 indexed citations
6.
Nevill, Thomas J., M. J. Barnett, Cynthia L. Toze, et al.. (2000). Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease with Rabbit Antithymocyte Globulin. Journal of Hematotherapy & Stem Cell Research. 9(3). 367–374. 53 indexed citations
7.
Toze, Cynthia L., John D. Shepherd, Joseph M. Connors, et al.. (2000). Allografting for indolent lymphoid neoplasms. Annals of Oncology. 11. S59–S61. 7 indexed citations
8.
Raptis, Anastasios, et al.. (1999). Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplantation. 24(11). 1259–1260. 19 indexed citations
9.
Hennemann, B., Y.K. Tam, Torsten Tonn, & Hans-Georg Klingemann. (1999). Expression of SCM-1alpha/Lymphotactin and SCM-1beta in Natural Killer Cells Is Upregulated by IL-2 and IL-12. DNA and Cell Biology. 18(7). 565–571. 11 indexed citations
10.
Klingemann, Hans-Georg. (1995). Introducing Graft-Versus-Leukemia into Autologous Stem Cell Transplantation. Journal of Hematotherapy. 4(4). 261–267. 2 indexed citations
11.
Klingemann, Hans-Georg, et al.. (1992). Preclinical Evaluation of a Bone‐Marrow Autograft Culture Procedure for Generating Lymphokine‐Activated Killer Cells in Vitro. Canadian Journal of Infectious Diseases and Medical Microbiology. 3(B). 123–127. 2 indexed citations
12.
Nevill, T.J., JD Shepherd, Donna Reece, et al.. (1992). Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT.. PubMed. 10(5). 445–50. 40 indexed citations
13.
Cuthbert, R, G. L. Phillips, M. J. Barnett, et al.. (1992). Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy.. PubMed. 10(5). 451–5. 30 indexed citations
14.
Phillips, G. L., John D. Shepherd, M. J. Barnett, et al.. (1991). Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.. Journal of Clinical Oncology. 9(10). 1880–1888. 39 indexed citations
15.
Shepherd, John D., et al.. (1991). Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.. Journal of Clinical Oncology. 9(11). 2016–2020. 119 indexed citations
16.
Reece, Donna, Michael J. Barnett, J M Connors, et al.. (1991). Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.. Journal of Clinical Oncology. 9(10). 1871–1879. 149 indexed citations
17.
Nevill, Thomas J., M. J. Barnett, Hans-Georg Klingemann, et al.. (1991). Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation.. Journal of Clinical Oncology. 9(7). 1224–1232. 58 indexed citations
18.
Phillips, G. L., Donna Reece, M. J. Barnett, et al.. (1989). Allogeneic marrow transplantation for refractory Hodgkin's disease.. Journal of Clinical Oncology. 7(8). 1039–1045. 49 indexed citations
19.
Klingemann, Hans-Georg, et al.. (1988). A Guide to Bone Marrow Transplantation. 20 indexed citations
20.
Klingemann, Hans-Georg, et al.. (1981). Antithrombin III Substitution In Acute Hepatic Failure Due To CCl4 Intoxication. Thrombosis and Haemostasis. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Christopher Ehmann Breakdown of academic impact, for papers by Rosanna Scimè Breakdown of academic impact, for papers by N. Schwella Breakdown of academic impact, for papers by Alberto M. Marmont Breakdown of academic impact, for papers by Ginna G. Laport Breakdown of academic impact, for papers by Maurizio Musso Breakdown of academic impact, for papers by YL Kwong Breakdown of academic impact, for papers by B. Glaß Breakdown of academic impact, for papers by Alessandra Sperotto Breakdown of academic impact, for papers by A Marmont
Rankless by CCL
2026